Riskpilot← Back to searchSign inGet full accessDr. Roashan AB
ABIn liquidationOrg 5591897003General medical practice activities · NACE 8621Est. 20191 employees
Revenue 2025
SEK 0
EBITDA margin
—
-104% vs 2024
Equity ratio
95.6%
Financial strength
Net profit 2025
SEK -8K
-104% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -8K | -104% |
| Net profit | SEK -8K | -104% |
| Total assets | SEK 144K | -71% |
| Equity | SEK 137K | -72% |
| Employees | 1 | — |
Legal name
Dr. Roashan AB
Org number
5591897003
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 januari 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Konsulentverksamhet inom primärvården. Läkarbemanning av vårdcentraler, hemsjukvård och särskildboende.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 871 | 1 868 | 1 180 | 0 | 0 |
| Staff expenses | — | −1 478 | −1 028 | −0 | — |
| EBITDA | 807 | −114 | −60 | 188 | −8 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 807 | −114 | −60 | 188 | −8 |
| Net financials | −3 | −2 | −3 | 0 | −0 |
| Profit before tax | 805 | −116 | −63 | 188 | −8 |
| Tax | −166 | — | — | −2 | — |
| Net profit | 639 | −116 | −63 | 186 | −8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 367 | 1 992 | 659 | 501 | 144 |
| Equity | 1 615 | 1 498 | 659 | 495 | 137 |
| Long-term debt | 233 | 51 | 0 | 4 | 4 |
| Short-term debt | 519 | 442 | 0 | 2 | 2 |
| Total debt | 752 | 493 | 0 | 6 | 6 |
EBITDA margin
-760000.0%
This company
15.8%
Market median
-4810227% vs market
20212025
Equity ratio
95.6%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
-5.5%
This company
18.4%
Market median
-130% vs market
20212025
Net profit margin
-760200.0%
This company
8.1%
Market median
-9385285% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2026 |
BJ External Signatory | External Signatory | 2026 |
AE External Signatory | External Signatory | 2026 |
UM External Signatory | External Signatory | 2026 |
EJ Liquidator | Liquidator | 2026 |
| Former (1) | ||
NK Authorized Recipient of Service | Authorized Recipient of Service | 2024 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2026 | |
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Roashan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Anna Elisabet Viktoria Björk | External Signatory | 0 companies |
| Nangialai Khalil | Authorized Recipient of Service | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Liquidator | 0 companies |
| Elaha Nazir | Deputy Board Member | 0 companies |
| Mansoor Roashan | Board of Directors | 0 companies |